TrialBMC infectious diseases2014

A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.

Varsha K Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.